Therapeutic potential of the original incretin hormone glucose-dependent insulinotropic polypeptide: diabetes, obesity, osteoporosis and Alzheimer's disease?

Author： Irwin Nigel   Gault Victor   Flatt Peter R  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.19, Iss.9, 2010-09, pp. : 1039-1048

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Structurally Modified Analogues of Glucagon-Like Peptide-1 (GLP-1) and Glucose-Dependent Insulinotropic Polypeptide (GIP) As Future Antidiabetic Agents

By  

Current Pharmaceutical Design, Vol. 10, Iss. 29, 2004-11 ,pp. : 3651-3662

Bentham Science Publishers

Access to resources Recommend Favorite

Glucose-dependent insulinotropic effects of JTT-608, a novel antidiabetic compound

By Furukawa N.   Ohta T.   Noguchi T.   Yonemori F.   Wakitani K.  

European Journal of Pharmacology, Vol. 371, Iss. 1, 1999-04 ,pp. : 51-58

Elsevier

Access to resources Recommend Favorite

Therapeutic Potential of Copper Chelation with Triethylenetetramine in Managing Diabetes Mellitus and Alzheimer's Disease

By Cooper Garth J.S.  

Drugs, Vol. 71, Iss. 10, 2011-07 ,pp. : 1281-1320

Adis International

Access to resources Recommend Favorite

Therapeutic Potential in Alzheimer Disease

By  

Current Medicinal Chemistry, Vol. 9, Iss. 17, 2002-09 ,pp. : 1605-1610

Bentham Science Publishers

Access to resources Recommend Favorite

The therapeutic potential of the endocannabinoid system for Alzheimer's disease

By Karl Tim   Cheng David   Garner Brett   Arnold Jonathon C.  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 4, 2012-04 ,pp. : 407-420

Informa Healthcare

Access to resources Recommend Favorite